Biotechnology and Pharmaceutical Recruitment

One of our clients, Allergan, faced a major compliance issue related to charges from the FDA for off-label promotion of Botox.

The FDA accused Allergan of marketing Botox for uses that were not officially approved, such as treating migraine headaches, muscle stiffness, and overactive bladder. These practices violated FDA regulations, which strictly prohibit pharmaceutical companies from promoting drugs for unapproved uses.

As a result, Allergan had to deal with legal actions, fines, and more scrutiny from regulators. They reached a settlement with the Department of Justice (DOJ), agreeing to pay large penalties and follow stricter oversight of their marketing practices to ensure compliance with FDA standards.

Life Science Partner helped Allergan build a strong compliance team to navigate these challenges. Our expertise in pharmaceutical recruitment allowed Allergan to meet FDA regulations, protect their business, and avoid future legal risks.